Improving Patient Access to Care and Treatment Act
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-11-01 | Committee | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. | House committee actions |
| 2021-11-15 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2021-11-12 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-11-12 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-11-12 | IntroReferral | Introduced in House | Library of Congress |